Results 151 to 160 of about 23,609 (230)

Actinium-225-PSMA-617 treatment in a patient with advanced prostate cancer causes secondary myelofibrosis: a case report and literature review. [PDF]

Front Med (Lausanne)
Wang Z, Tang W, Liu M, Xie Z, Li Y, Du J, Wu T.   +6 more
europepmc   +1 more source

Development of Dermatomyositis in a Patient with Primary Myelofibrosis [PDF]

, 2001
Hülya Taşkapan, Şebnem Gürsoy, Mustafa Çetın, Oktay Oymak, Ömer Özbakır   +4 more
openalex   +1 more source

Myelofibrosis: Treatment Options After Ruxolitinib Failure. [PDF]

Curr Oncol
Stuckey R, Segura Díaz A, Gómez-Casares MT.   +2 more
europepmc   +1 more source

Splenectomy and hemopoietic stem cell transplantation for myelofibrosis [PDF]

, 2001
Zihai Li, Ted Gooley, Frederick R. Appelbaum, H. Joachim Deeg   +3 more
openalex   +1 more source

Gene Expression Analysis of Autophagy Markers in Primary and Secondary Myelofibrosis. [PDF]

J Clin Med
Medugorac M, Glick KM, Livun A, Lucijanic M, Galusic D, Kusec R.   +5 more
europepmc   +1 more source

Massive Bleeding from Colonic Adenoma in a Patient with Idiopathic Myelofibrosis.

, 1995
Hitoshi Kotanagi, Yoshiaki Saitoh, Yutaka Shibata, Osamu Aizawa, Junichi Tanaka, Kenji Koyama   +5 more
openalex   +2 more sources

Spontaneous remission of juvenile idiopathic myelofibrosis [PDF]

, 2001
Asutosh Sah, Adrian Minford, L. A. Parapia   +2 more
openalex   +1 more source

Ruxolitinib and Hepatitis-B Virus Reactivation: A Clinical Concern Requiring Prophylactic Management. [PDF]

Pak J Med Sci
Park JE, Yang J, Han S.
europepmc   +1 more source

Stem-Cell Transplantation for Myelofibrosis [PDF]

, 2001
Deeg Hj, FR Appelbaum
openalex   +1 more source

Indirect treatment comparison of momelotinib vs fedratinib safety in patients with myelofibrosis. [PDF]

Future Oncol
Masarova L, Verstovsek S, Palandri F, Mesa R, Harrison C, Sajeev G, Gorsh B, Simpson R, Cho S, Wang Z, Ellis C, Conlon S, Signorovitch J.   +12 more
europepmc   +1 more source